Antifibrillatory effect of beta-adrenergic agonists.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D002628:Chemoreceptor Cells / Q000187:drug effects; D002725:Chloroform; D004285:Dogs; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010656:Phenylephrine / Q000627:therapeutic use; D011427:Propiophenones / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000139:chemically induced / Q000517:prevention & control*
D000318:Adrenergic beta-Agonists; D000889:Anti-Arrhythmia Agents; D011427:Propiophenones; D010656:Phenylephrine; D009921:Metaproterenol; D002725:Chloroform; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine